Alzamend Neuro
2.45
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About Alzamend Neuro
Alzamend Neuro, Inc., una compañía biofarmacéutica en etapa clínica temprana, se enfoca en desarrollar varios productos para el tratamiento de trastornos neurodegenerativos y psiquiátricos. La cartera de productos de la compañía incluye AL001 que se encuentra en el ensayo clínico de Fase II, que ofrece una combinación terapéutica de litio, prolina y salicilato para el tratamiento de la enfermedad de Alzheimer, el trastorno bipolar, el trastorno de estrés postraumático, el trastorno depresivo mayor y otras enfermedades neurodegenerativas. y trastornos psiquiátricos; y AL002 que completó la etapa preclínica, que utiliza un método que usa una célula sensibilizada con péptido mutante como una vacuna terapéutica basada en células para restaurar la capacidad del sistema inmunológico de un paciente para combatir la enfermedad de Alzheimer. Alzamend Neuro, Inc. se incorporó en 2016 y tiene su sede en Atlanta, Georgia.
Trade GPT
Similar Stocks
© 2025 Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.
Rockalpha Limited, operates from its Singapore headquarters at CapitaSky 808, 79 Robinson Road, Singapore 068897, with a regional office at Level 6, Core C, Cyberport 3, 100 Cyberport Road, Hong Kong.